1. P23 Assessing the Long-term Outcomes of Ocrelizumab Treatment in Germany – CONFIDENCE Baseline Characteristics. Issue 4 (April 2020) Authors: van Hall, V.; Hartung, H.P.; Dirks, P.; Eggebrecht, J.; Hieke-Schulz, S.; Leemhuis, J.; Wormser, D.; Ziemssen, T. Journal: Clinical neurophysiology Issue: Volume 131:Issue 4(2020:Apr.) Page Start: e187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗